rs117132825

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_022095.4(ZNF335):​c.1963C>T​(p.Pro655Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.012 in 1,614,152 control chromosomes in the GnomAD database, including 259 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0076 ( 16 hom., cov: 32)
Exomes 𝑓: 0.012 ( 243 hom. )

Consequence

ZNF335
NM_022095.4 missense

Scores

1
1
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 2.93

Publications

12 publications found
Variant links:
Genes affected
ZNF335 (HGNC:15807): (zinc finger protein 335) The protein encoded by this gene enhances transcriptional activation by ligand-bound nuclear hormone receptors. However, it does this not by direct interaction with the receptor, but by direct interaction with the nuclear hormone receptor transcriptional coactivator NRC. The encoded protein may function by altering local chromatin structure. [provided by RefSeq, Jul 2008]
ZNF335 Gene-Disease associations (from GenCC):
  • microcephalic primordial dwarfism due to ZNF335 deficiency
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005218357).
BP6
Variant 20-45960265-G-A is Benign according to our data. Variant chr20-45960265-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 212643.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0076 (1158/152282) while in subpopulation SAS AF = 0.0447 (216/4828). AF 95% confidence interval is 0.0399. There are 16 homozygotes in GnomAd4. There are 583 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 16 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ZNF335NM_022095.4 linkc.1963C>T p.Pro655Ser missense_variant Exon 14 of 28 ENST00000322927.3 NP_071378.1 Q9H4Z2-1Q8IW09

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ZNF335ENST00000322927.3 linkc.1963C>T p.Pro655Ser missense_variant Exon 14 of 28 1 NM_022095.4 ENSP00000325326.2 Q9H4Z2-1

Frequencies

GnomAD3 genomes
AF:
0.00763
AC:
1161
AN:
152164
Hom.:
16
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00210
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00759
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.0453
Gnomad FIN
AF:
0.00198
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0101
Gnomad OTH
AF:
0.00718
GnomAD2 exomes
AF:
0.0117
AC:
2944
AN:
251418
AF XY:
0.0139
show subpopulations
Gnomad AFR exome
AF:
0.00129
Gnomad AMR exome
AF:
0.00523
Gnomad ASJ exome
AF:
0.00367
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00328
Gnomad NFE exome
AF:
0.0101
Gnomad OTH exome
AF:
0.0104
GnomAD4 exome
AF:
0.0124
AC:
18177
AN:
1461870
Hom.:
243
Cov.:
33
AF XY:
0.0136
AC XY:
9875
AN XY:
727238
show subpopulations
African (AFR)
AF:
0.00152
AC:
51
AN:
33480
American (AMR)
AF:
0.00537
AC:
240
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00306
AC:
80
AN:
26136
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39700
South Asian (SAS)
AF:
0.0454
AC:
3918
AN:
86248
European-Finnish (FIN)
AF:
0.00326
AC:
174
AN:
53420
Middle Eastern (MID)
AF:
0.0114
AC:
66
AN:
5768
European-Non Finnish (NFE)
AF:
0.0116
AC:
12893
AN:
1112002
Other (OTH)
AF:
0.0125
AC:
752
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
1120
2241
3361
4482
5602
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
514
1028
1542
2056
2570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00760
AC:
1158
AN:
152282
Hom.:
16
Cov.:
32
AF XY:
0.00783
AC XY:
583
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.00209
AC:
87
AN:
41556
American (AMR)
AF:
0.00758
AC:
116
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00259
AC:
9
AN:
3470
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5188
South Asian (SAS)
AF:
0.0447
AC:
216
AN:
4828
European-Finnish (FIN)
AF:
0.00198
AC:
21
AN:
10620
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0102
AC:
691
AN:
68008
Other (OTH)
AF:
0.00710
AC:
15
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
58
116
174
232
290
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00954
Hom.:
33
Bravo
AF:
0.00622
TwinsUK
AF:
0.0127
AC:
47
ALSPAC
AF:
0.0127
AC:
49
ESP6500AA
AF:
0.00204
AC:
9
ESP6500EA
AF:
0.00942
AC:
81
ExAC
AF:
0.0120
AC:
1452
Asia WGS
AF:
0.0140
AC:
49
AN:
3478
EpiCase
AF:
0.0107
EpiControl
AF:
0.0109

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
Dec 28, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 27, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 25, 2023
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

not specified Uncertain:1
Jul 24, 2014
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ZNF335-related disorder Benign:1
Apr 05, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.099
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
21
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.066
T
Eigen
Benign
0.029
Eigen_PC
Benign
0.15
FATHMM_MKL
Benign
0.68
D
LIST_S2
Benign
0.82
T
MetaRNN
Benign
0.0052
T
MetaSVM
Benign
-0.87
T
MutationAssessor
Benign
0.81
L
PhyloP100
2.9
PrimateAI
Uncertain
0.61
T
PROVEAN
Benign
0.92
N
REVEL
Benign
0.16
Sift
Benign
0.23
T
Sift4G
Benign
0.47
T
Polyphen
0.92
P
Vest4
0.14
MPC
0.36
ClinPred
0.016
T
GERP RS
4.2
Varity_R
0.024
gMVP
0.44
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117132825; hg19: chr20-44588904; COSMIC: COSV99071815; COSMIC: COSV99071815; API